Leuprolide (Lupron)
Overview
A synthetic nonapeptide GnRH agonist approximately 15-fold more potent than native GnRH. After an initial stimulatory phase (flare effect) lasting 1-2 weeks, chronic leuprolide administration downregulates pituitary GnRH receptors, resulting in profound suppression of LH, FSH, and downstream sex steroids.
Mechanism of Action
This chemical castration effect is exploited in treating hormone-sensitive cancers, endometriosis, and precocious puberty..
Research Summary & Key Findings
FDA-approved for prostate cancer, endometriosis, uterine fibroids, central precocious puberty, and as part of IVF protocols. Depot formulations available for 1-, 3-, 4-, and 6-month dosing intervals. In prostate cancer, achieves castrate testosterone levels in >95% of patients. EMBARK trial (2023) demonstrated benefit in biochemically recurrent prostate cancer.
Clinical Status
Leuprolide (Lupron) has received FDA approval and is available for clinical use under appropriate medical supervision. Consult a qualified healthcare provider for prescribing information.
Administration Routes
Related Peptides in Reproductive
Goserelin (Zoladex)
FDA ApprovedA synthetic decapeptide GnRH agonist administered as a biodegradable subcutaneous implant that provides sustained drug r...
View detailsCetrorelix (Cetrotide)
FDA ApprovedA synthetic decapeptide GnRH antagonist that competitively blocks pituitary GnRH receptors, producing immediate and dose...
View detailsGanirelix
FDA ApprovedA synthetic decapeptide GnRH antagonist that competitively and reversibly blocks GnRH receptors on pituitary gonadotroph...
View detailsCarbetocin
In Clinical TrialsA long-acting synthetic analog of oxytocin with a modified disulfide bridge that confers resistance to enzymatic degrada...
View detailsFind a Provider
Find a verified provider who offers Leuprolide (Lupron) therapy in your area.
Browse Provider MapFind a Pharmacy
Browse PCAB-accredited and FDA 503B-registered compounding pharmacies that supply Leuprolide (Lupron).
Pharmacy DirectoryJoin the Association
Access exclusive peptide protocols, provider resources, and community support.
List Your PracticeDisclaimer: This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide therapy. The Peptide Association does not endorse or recommend any specific treatment protocol.